Stryker recently announced that it has completed the acquisition of Amplitude Vascular Systems (AVS), developer of a next-generation intravascular lithotripsy (IVL) platform designed to treat complex peripheral arterial disease (PAD). “This acquisition is a significant milestone in expanding our peripheral vascular portfolio and enhancing our ability to address challenging arterial disease,” said Kevin Lobo, chair and CEO, Stryker. “By integrati…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.